Dermaliq Therapeutics
Dr. Hughes-Formella is CSO and co-founder of Dermaliq. She has almost three decades of experience in the development of of topical products and transdermals for a wide range of indications including psoriasis, atopic dermatitis, acne, rosacea, skin infections, pain, wound healing, and aesthetic products. Prior to joining Dermaliq, Dr. Hughes-Formella provided independent consulting services to the global pharmaceutical and CRO industry for 5+ years after holding a management position in a niche CRO specialized in the conduct of dermatological trials for 22+ years. She earned her MS and PhD at the Department of Physiology and Pharmacology, College of Veterinary Medicine, University of Georgia, Athens.
This person is not in any teams
This person is not in any offices
Dermaliq Therapeutics
Dermaliq is developing the next generation of skin care therapies to enhance targeted penetration into skin tissues and to reduce unwanted side effects for millions of patients